Genetic Signatures Limited announced the appointment of Dr. Tony Radford to the Board of Directors of the company. Tony Radford has a PhD from La Trobe University, and was a member of the CSIRO team that invented the QuantiFERON method for Cellular Immune based diagnostics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 AUD | -.--% | -.--% | +67.82% |
May. 27 | Genetic Signatures Ceases Development of EasyScreen Essentials Respiratory Product for US Market; Shares Down 11% | MT |
Apr. 30 | Genetic Signatures Appoints Interim CEO | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.82% | 90.41M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.37% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- GSS Stock
- News Genetic Signatures Limited
- Genetic Signatures Limited Appoints Tony Radford to the Board of Directors